[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337455-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337455-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","atypical-inflammatory-kinase-ikbke-phosphorylates-and-inactivates-foxa1-to-promote-liver-tumorigenesis","Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis","","FoxA1 is a key liver differentiation factor with context-dependent oncogenic roles in other cancers, yet its upstream regulation in liver tumorigenesis is unclear. This study shows FoxA1 functions as a tumor suppressor in liver cancer. CRISPR-based kinome screening identifies the noncanonical inflammatory kinase IKBKE as an inhibitor of FoxA1 transcriptional activity. IKBKE directly binds and phosphorylates FoxA1, reducing complex formation and DNA interaction, thereby elevating hepatocellular malignancies. Knock-in mouse models demonstrate that nonphosphorylated FoxA1 delays tumorigenesis, whereas phosphomimetic FoxA1 phenocopies FoxA1 loss with developmental defects and liver inflammation. IKBKE deficiency also delays DEN-induced tumor development, supporting FoxA1 as an IKBKE substrate and therapeutic target for HCC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/atypical-inflammatory-kinase-ikbke-phosphorylates-and-inactivates-foxa1-to-promote-liver-tumorigenesis/337455/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/atypical-inflammatory-kinase-ikbke-phosphorylates-and-inactivates-foxa1-to-promote-liver-tumorigenesis/337455.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the role of FoxA1 in liver cancer according to this study?","Question",{"text":63,"@type":64},"FoxA1 acts as a tumor suppressor in liver cancer, contrary to oncogenic roles described in other tumor contexts.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does IKBKE regulate FoxA1 to influence liver tumorigenesis?",{"text":68,"@type":64},"IKBKE directly binds to and phosphorylates FoxA1, reducing FoxA1 complex formation and DNA interaction, which leads to increased hepatocellular malignancies.",{"name":70,"@type":61,"acceptedAnswer":71},"What do the different FoxA1 knock-in mouse models show?",{"text":72,"@type":64},"Nonphosphorylated Foxa1 knock-in mice delay liver tumorigenesis, while phospho-mimic knock-in mice phenocopy FoxA1 knockout with developmental defects and liver inflammation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337455,1790182328,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","CANCER  \nAtypical inflammatory kinase IKBKE phosphorylatesand inactivates FoxA1 to promote liver tumorigenesis  \nBing Gao1,2†, Xueji Wu2†, Lang Bu2†, Qiwei Jiang2†, Lei Wang2, Haining Liu1,2, Xiaomei Zhang2, Yuanzhong Wu3, Xiaoxing Li1,2, Jingting Li2, Ying Liang4*, Lixia Xu2,5*, Wei Xie2*, Jianping Guo2*  \nPhysiologically, FoxA1 plays a key role in liver differentiation and development, and pathologically exhibits anoncogenic role in prostate and breast cancers. However, its role and upstream regulation in liver tumorigenesis remain unclear. Here, we demonstrate that FoxA1 acts as a tumor suppressor in liver cancer. Using a CRISPR-based kinome screening approach, noncanonical inflammatory kinase IKBKE has been identified to inhibit FoxA1 transcriptional activity. Notably, IKBKE directly binds to and phosphorylates FoxA1 to reduce its complex formation and DNA interaction, leading to elevated hepatocellular malignancies. Nonphosphorylated mimic Foxa1 knock-in mice markedly delay liver tumorigenesis in hydrodynamic transfection murine models, while phospho-mimic Foxa1 knock-in phenocopy Foxa1 knockout mice to exhibit developmental defects and liver inflammation. Notably, Ikbke knockout delays diethylnitrosamine (DEN)-induced mouse liver tumor development. Together, our findings not only reveal FoxA1 as a bona fide substrate and negative nuclear effector of IKBKE in hepatocellular carcinioma (HCC) but also provide a promising strategy to target IKBEK for HCC therapy.  \ncopyright © 2024 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nLiver cancer is the fourth leading cause of cancer death in both sexes (8.2% of all cancer deaths) (1). It is worth noting that hepatocellular carcinoma (HCC), the most common form of liver cancer, is usually caused by excessive alcohol consumption, viral hepatitis [hepatitis B virus (HBV) and HCV)], or nonalcoholic fatty liver disease with inflammation that promotes liver fibrosis and tumorigenesis (2, 3). Therefore, HCC is considered an inflammatory disease. Thus, in amurine model of carcinogen-induced HCC, inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocytes successfully blocked HCC development (4). In addition, proinflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor (TNF), which activate STAT3 and nuclear factor κB (NF-κB) signaling, respectively, play major roles in initiation and progression of HCC (5, 6). Notably, inhibition of NF-κB increased hepatocyte proliferation in diethylnitrosamine (DEN)–induced and HBV surface antigen–driven HCC murine models (7, 8). However, there are currently no effective strategies to combat HCC by targeting the NF-κB pathway.  \nThe inhibitor of NF-κB kinase subunit epsilon (IKBKE) belongs to noncanonical IκB kinases. IKBKE and TNF receptor-associated factor (TANK)–binding kinase 1 (TBK1) have been reported to be involved in energy storage and inflammatory programs in the liver and adipose tissues, where abnormality of IKBKE contributes to obesity (9). In addition to regulating NF-κB (10) and STAT1–interferon regulatory factor 3/7 (IRF3/7)–mediated inflammatory signaling pathways (11), the function ofIKBKE in tumorigenesis has also been  \n1center of hepato-Pancreate-Biliary Surgery, the First Affiliated hospital, SunYat-sen University, Guangzhou, Guangdong, 510275, china. 2institute of Precision Medicine, the First Affiliated hospital, Sun Yat-sen University, Guangzhou, Guangdong 510275, china. 3State Key laboratory of Oncology in South china, collaborative innovation center for cancer Medicine, Sun Yat-sen University cancer center, Guangzhou, Guangdong 510060, china. 4department of nephrology, Guangzhou eighth People′s hospital, Guangzhou Medical University, Guangdong 510060, china. 5department of ","cbCait2QW0nHYBdS","https://ap.wps.com/l/cbCait2QW0nHYBdS","pdf",5559130,16,"English","# Introduction\n## Role of inflammation in HCC\n## IKBKE in noncanonical IκB kinase signaling\n## Background on FoxA1 in cancer","[{\"question\":\"What is the role of FoxA1 in liver cancer according to this study?\",\"answer\":\"FoxA1 acts as a tumor suppressor in liver cancer, contrary to oncogenic roles described in other tumor contexts.\"},{\"question\":\"How does IKBKE regulate FoxA1 to influence liver tumorigenesis?\",\"answer\":\"IKBKE directly binds to and phosphorylates FoxA1, reducing FoxA1 complex formation and DNA interaction, which leads to increased hepatocellular malignancies.\"},{\"question\":\"What do the different FoxA1 knock-in mouse models show?\",\"answer\":\"Nonphosphorylated Foxa1 knock-in mice delay liver tumorigenesis, while phospho-mimic knock-in mice phenocopy FoxA1 knockout with developmental defects and liver inflammation.\"}]","Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis | PDF",1790019216,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22356123f94b201ce67767762eda566b.webp",983,1250,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7813a95df1a11d8b43c1b215e2e84a95.webp",982,1249,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/845857955bd05d91dd23fda9a8947e47.webp",981,1248,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e46067d4d7f89c286d428b1508584e3.webp",980,1247]